{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:13:17Z","timestamp":1791688397288,"version":"4.3.4"},"reference-count":39,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To compare clinical features of patients with remitting seronegative symmetrical synovitis with pitting edema (RS3PE) and patients with polymyalgia rheumatica (PMR) and to explore the purported association between RS3PE and malignancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>We did a retrospective chart review of patients with RS3PE and PMR treated in a community-based hospital between January 2000 and December 2009. Outcomes assessed were clinical course of disease and associated malignancies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>We identified 28 patients with RS3PE and 123 with pure PMR. All patients with RS3PE fulfilled PMR criteria as well. Age, comorbidity, erythrocyte sedimentation rate, duration and progression of symptoms, treatment response to initial low-dose steroids, and steroid complication rates were similar in both groups. Patients with RS3PE were more likely to be male (79% vs 41%; p = 0.001) and to have a history of smoking (39% vs 15%; p = 0.008) and a higher rate of depression (11% vs 2%; p = 0.044) at diagnosis. Among those with RS3PE, hip pain was less common (39% vs 74%; p = 0.001) than in the PMR group. No patients with RS3PE and 6 patients with pure PMR (4.9%) developed another rheumatological disease during followup. Seven of 9 patients (78%) with concurrent cancer presented slightly more frequently with systemic symptoms compared to patients without cancer (48%; p = 0.098), especially with fatigue (56% vs 22%; p = 0.037) and anorexia (33% vs 9.0%; p = 0.047). Despite rigorous cancer screening in patients with RS3PE, however, the rate of associated malignancy was not statistically different from that of patients with pure PMR [2 (7%) vs 7 (6%), respectively; p = 0.673].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>Despite evidence that RS3PE is clinically distinct from PMR, we observed characteristics, treatment response, and outcomes like those expected in pure PMR. Compared to patients with pure PMR, patients with RS3PE are more likely to be male, to be depressed, and to smoke. Contrary to earlier studies, no clear association of RS3PE with malignancy was found despite rigorous cancer screening, although clinicians should be aware that patients with concurrent cancer may manifest more systemic signs and symptoms, as well as steroid resistance.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.110558","type":"journal-article","created":{"date-parts":[[2011,12,16]],"date-time":"2011-12-16T06:25:32Z","timestamp":1324016732000},"page":"148-153","source":"Crossref","is-referenced-by-count":39,"title":["Clinical Characteristics of Patients with Remitting Seronegative Symmetrical Synovitis with Pitting Edema Compared to Patients with Pure Polymyalgia Rheumatica"],"prefix":"10.3899","volume":"39","author":[{"given":"MAKIKO","family":"KIMURA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YASUHARU","family":"TOKUDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDETO","family":"OSHIAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUKI","family":"YOSHIDA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MASAKO","family":"UTSUNOMIYA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TATSUO","family":"KOBAYASHI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GAUTAM A.","family":"DESHPANDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KAZUO","family":"MATSUI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MITSUMASA","family":"KISHIMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2011,12,15]]},"reference":[{"key":"2018112909272422000_39.1.148.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1985.03360190069027"},{"key":"2018112909272422000_39.1.148.2","first-page":"633","article-title":"Remitting, seronegative, symmetrical synovitis with pitting edema \u2014 13 additional cases","volume":"17","author":"Russell","year":"1990","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.3","first-page":"1211","article-title":"The syndrome of seronegative symmetrical synovitis with pitting edema (RS3PE syndrome): A unique form of arthritis in the elderly? Report of 4 additional cases","volume":"16","author":"Chaouat","year":"1989","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/29.6.479"},{"key":"2018112909272422000_39.1.148.5","first-page":"414","article-title":"RS3PE syndrome","volume":"17","author":"Healey","year":"1990","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.6","first-page":"372","article-title":"RS3PE syndrome with unilateral involvement","volume":"21","author":"Olivieri","year":"1994","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.7","first-page":"249","article-title":"Remitting distal extremity swelling with pitting edema: a distinct syndrome or a clinical feature of different inflammatory rheumatic diseases?","volume":"24","author":"Olivieri","year":"1997","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.54.8.681"},{"key":"2018112909272422000_39.1.148.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.11.006"},{"key":"2018112909272422000_39.1.148.10","doi-asserted-by":"publisher","DOI":"10.1002\/art.23252"},{"key":"2018112909272422000_39.1.148.11","first-page":"475","article-title":"Amyloid arthropathy revealed by RS3PE syndrome","volume":"67","author":"Magy","year":"2000","journal-title":"Joint Bone Spine"},{"issue":"Suppl","key":"2018112909272422000_39.1.148.12","first-page":"S689","article-title":"Development of classification criteria for polymyalgia rheumatic (PMR): Results from an international, prospective, multi-center longitudinal study. ACR-EULAR Study Group for Development of Classification Criteria for PMR [abstract]","volume":"62","author":"Dasgupta","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2018112909272422000_39.1.148.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2008.03.008"},{"key":"2018112909272422000_39.1.148.14","first-page":"53","article-title":"Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) as the first manifestation of periarteritis nodosa. Report of a case","volume":"62","author":"Billey","year":"1995","journal-title":"Rev Rhum Engl Ed"},{"key":"2018112909272422000_39.1.148.15","doi-asserted-by":"publisher","DOI":"10.1007\/PL00011192"},{"key":"2018112909272422000_39.1.148.16","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.43.143"},{"key":"2018112909272422000_39.1.148.17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.52.1.85"},{"key":"2018112909272422000_39.1.148.18","first-page":"115","article-title":"Remitting seronegative symmetrical synovitis with pitting edema (RS3PE): A form of paraneoplastic polyarthritis?","volume":"26","author":"Sibilia","year":"1999","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.19","first-page":"741","article-title":"Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema","volume":"17","author":"Cantini","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909272422000_39.1.148.20","first-page":"390","article-title":"Remitting seronegative symmetrical synovitis with pitting edema syndrome associated with cryptogenic hepatocellular carcinoma [letter]","volume":"17","author":"Nakashima","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909272422000_39.1.148.21","doi-asserted-by":"publisher","DOI":"10.1136\/ard.60.4.429"},{"key":"2018112909272422000_39.1.148.22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.29333\/ejgm\/82184","article-title":"Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome and malignancy","volume":"1","author":"Sayarlioglu","year":"2004","journal-title":"Eur J Gen Med"},{"key":"2018112909272422000_39.1.148.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380311"},{"key":"2018112909272422000_39.1.148.24","first-page":"333","article-title":"The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema","volume":"24","author":"Olive","year":"1997","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/PL00011218","article-title":"Remitting seronegative symmetrical synovitis with pitting oedema: A study of 12 cases","volume":"21","author":"Paira","year":"2002","journal-title":"Clin Rheumatol"},{"key":"2018112909272422000_39.1.148.26","doi-asserted-by":"publisher","DOI":"10.4065\/82.12.1510"},{"key":"2018112909272422000_39.1.148.27","first-page":"205","article-title":"Polymyalgia rheumatica and giant cell arteritis: A 5-year epidemiological and clinical study in Reggio Emilia, Italy","volume":"5","author":"Salvarani","year":"1987","journal-title":"Clin Exp Rheumatol"},{"key":"2018112909272422000_39.1.148.28","doi-asserted-by":"publisher","DOI":"10.1136\/ard.58.4.230"},{"key":"2018112909272422000_39.1.148.29","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/34.9.889"},{"key":"2018112909272422000_39.1.148.30","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199807)41:7<1221::AID-ART12>3.0.CO;2-W"},{"key":"2018112909272422000_39.1.148.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.3.283"},{"key":"2018112909272422000_39.1.148.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken343"},{"key":"2018112909272422000_39.1.148.33","first-page":"65","article-title":"Relapse in a population based cohort of patients with polymyalgia rheumatica","volume":"32","author":"Kremers","year":"2005","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/art.1780390110","article-title":"Distal extremity swelling with pitting edema in polymyalgia rheumatica. Report of nineteen cases","volume":"39","author":"Salvarani","year":"1996","journal-title":"Arthritis Rheum"},{"key":"2018112909272422000_39.1.148.35","doi-asserted-by":"publisher","DOI":"10.3109\/03009747409097138"},{"key":"2018112909272422000_39.1.148.36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0954-6820.1981.tb11604.x","article-title":"Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica","volume":"209","author":"Bengtsson","year":"1981","journal-title":"Acta Med Scand"},{"key":"2018112909272422000_39.1.148.37","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780300308"},{"key":"2018112909272422000_39.1.148.38","first-page":"1335","article-title":"Cancer in association with polymyalgia rheumatica and temporal arteritis","volume":"20","author":"Haga","year":"1993","journal-title":"J Rheumatol"},{"key":"2018112909272422000_39.1.148.39","first-page":"270","article-title":"Developing classification criteria for polymyalgia rheumatica: Comparison of views from an expert panel and wider survey","volume":"35","author":"Dasgupta","year":"2008","journal-title":"J Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.110558","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T18:08:26Z","timestamp":1543514906000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.110558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1,1]]},"published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.3899\/jrheum.110558"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.110558","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,15]]}}}